Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$4.3 million.

  • Rockwell Medical's Cash from Investing Activities rose 2949.93% to -$4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.7 million, marking a year-over-year decrease of 8784.64%. This contributed to the annual value of -$4.9 million for FY2024, which is 5980.3% down from last year.
  • Latest data reveals that Rockwell Medical reported Cash from Investing Activities of -$4.3 million as of Q3 2025, which was up 2949.93% from -$103000.0 recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Cash from Investing Activities peaked at $9.1 million during Q1 2022, and registered a low of -$14.7 million during Q3 2022.
  • For the 5-year period, Rockwell Medical's Cash from Investing Activities averaged around -$758368.4, with its median value being -$64000.0 (2023).
  • In the last 5 years, Rockwell Medical's Cash from Investing Activities plummeted by 97741.94% in 2022 and then soared by 278281.25% in 2024.
  • Rockwell Medical's Cash from Investing Activities (Quarter) stood at $540000.0 in 2021, then soared by 495.93% to $3.2 million in 2022, then plummeted by 37.6% to $2.0 million in 2023, then plummeted by 116.53% to -$332000.0 in 2024, then plummeted by 1197.89% to -$4.3 million in 2025.
  • Its Cash from Investing Activities was -$4.3 million in Q3 2025, compared to -$103000.0 in Q2 2025 and -$1000.0 in Q1 2025.